Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis
Eur Respir J
.
2022 Apr 21;59(4):2200024.
doi: 10.1183/13993003.00024-2022.
Print 2022 Apr.
Authors
Tim J M Wallis
1
2
,
Eyjólfur Gudmundsson
3
,
Katarina Pontoppidan
4
,
Nesrin Mogulkoc
5
,
Recep Savaş
6
,
Ömer Selim Unat
5
,
Katharine Vedwan
7
,
Sobana Battison
7
,
Fiona J Thompson
4
,
Christopher J Brereton
4
2
,
Ben G Marshall
4
2
,
Sophie V Fletcher
4
2
,
Luca Richeldi
4
8
,
Joseph Jacob
3
9
,
Mark G Jones
4
2
Affiliations
1
National Institute for Health Research Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK
[email protected]
.
2
School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
3
Centre for Medical Image Computing, University College London, London, UK.
4
National Institute for Health Research Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
5
Dept of Respiratory Medicine, Ege University Hospital, Izmir, Turkey.
6
Dept of Radiology, Ege University Hospital, Izmir, Turkey.
7
Dept of Cardiothoracic Radiology, University Hospital Southampton, Southampton, UK.
8
Unità Operativa Complessa di Pneumologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.
9
UCL Respiratory, University College London, London, UK.
PMID:
35115340
PMCID:
PMC7615162
DOI:
10.1183/13993003.00024-2022
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Idiopathic Pulmonary Fibrosis* / complications
Lymphadenopathy*
Mediastinum
Grants and funding
WT_/Wellcome Trust/United Kingdom
209553/WT_/Wellcome Trust/United Kingdom
209553/Z/17/Z/WT_/Wellcome Trust/United Kingdom
DH_/Department of Health/United Kingdom